|
1
|
Harris RE, Beebe-Donk J, Doss H and Burr
Doss D: Aspirin, ibuprofen, and other non-steroidal
anti-inflammatory drugs in cancer prevention: A critical review of
non-selective COX-2 blockade (review). Oncol R. 13:559–583.
2005.
|
|
2
|
Umar A, Steele VE, Menter DG and Hawk ET:
Mechanisms of nonsteroidal anti-inflammatory drugs in cancer
prevention. Semin Oncol. 43:65–77. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rothwell PM, Fowkes FG, Belch JF, Ogawa H,
Warlow CP and Meade TW: Effect of daily aspirin on long-term risk
of death due to cancer: Analysis of individual patient data from
randomised trials. Lancet. 377:31–41. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rothwell PM, Wilson M, Elwin CE, Norrving
B, Algra A, Warlow CP and Meade TW: Long-term effect of aspirin on
colorectal cancer incidence and mortality: 20-year follow-up of
five randomised trials. Lancet. 376:1741–1750. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rothwell PM, Wilson M, Price JF, Belch JF,
Meade TW and Mehta Z: Effect of daily aspirin on risk of cancer
metastasis: A study of incident cancers during randomised
controlled trials. Lancet. 379:1591–1601. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chan AT, Giovannucci EL, Meyerhardt JA,
Schernhammer ES, Wu K and Fuchs CS: Aspirin dose and duration of
use and risk of colorectal cancer in men. Gastroenterology.
134:21–28. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fajardo AM and Piazza GA: Chemoprevention
in gastrointestinal physiology and disease. Anti-inflammatory
approaches for colorectal cancer chemoprevention. Am J Physiol
Gastrointest Liver Physiol. 309:G59–G70. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Matos P and Jordan P: Beyond
COX-inhibition: ‘Side-effects’ of ibuprofen on neoplastic
development and progression. Curr Pharm Des. 21:2978–2982. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lichtenberger LM, Fang D, Bick RJ,
Poindexter BJ, Phan T, Bergeron AL, Pradhan S, Dial EJ and Vijayan
KV: Unlocking Aspirin's chemopreventive activity: Role of
irreversibly inhibiting platelet cyclooxygenase-1. Cancer Prev Res
(Phila). 10:142–152. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Parang B, Barrett CW and Williams CS:
AOM/DSS model of colitis-associated cancer. Methods Mol Biol.
1422:297–307. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Byun SY, Kim DB and Kim E: Curcumin
ameliorates the tumor-enhancing effects of a high-protein diet in
an azoxymethane-induced mouse model of colon carcinogenesis. Nutr
Res. 35:726–735. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yamaguchi M, Takai S, Hosono A and Seki T:
Bovine milk-derived alpha-lactalbumin inhibits colon inflammation
and carcinogenesis in azoxymethane and dextran sodium
sulfate-treated mice. Biosci Biotechnol Biochem. 78:672–679. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tian Y, Ye Y, Gao W, Chen H, Song T, Wang
D, Mao X and Ren C: Aspirin promotes apoptosis in a murine model of
colorectal cancer by mechanisms involving downregulation of
IL-6-STAT3 signaling pathway. Int J Colorectal Dis. 26:13–22. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yao M, Kargman S, Lam EC, Kelly CR, Zheng
Y, Luk P, Kwong E, Evans JF and Wolfe MM: Inhibition of
cyclooxygenase-2 by rofecoxib attenuates the growth and metastatic
potential of colorectal carcinoma in mice. Cancer Res. 63:586–592.
2003.PubMed/NCBI
|
|
15
|
Yao M, Zhou W, Sangha S, Albert A, Chang
AJ, Liu TC and Wolfe MM: Effects of nonselective cyclooxygenase
inhibition with low-dose ibuprofen on tumor growth, angiogenesis,
metastasis, and survival in a mouse model of colorectal cancer.
Clin Cancer Res. 11:1618–1628. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sandström R, Gelin J and Lundholm K: The
effect of indomethacin on food and water intake, motor activity and
survival in tumour-bearing rats. Eur J Cancer. 26:811–814. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Johnson SD and Young MR: Indomethacin
treatment of mice with premalignant oral lesions sustains cytokine
production and slows progression to cancer. Front Immunol.
7:3792016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lundholm K, Daneryd P, Körner U, Hyltander
A and Bosaeus I: Evidence that long-term COX-treatment improves
energy homeostasis and body composition in cancer patients with
progressive cachexia. Int J Oncol. 24:505–512. 2004.PubMed/NCBI
|
|
19
|
Lundholm K, Gelin J, Hyltander A, Lönnroth
C, Sandström R, Svaninger G, Körner U, Gülich M, Kärrefors I, Norli
B, et al: Anti-inflammatory treatment may prolong survival in
undernourished patients with metastatic solid tumors. Cancer Res.
54:5602–5606. 1994.PubMed/NCBI
|
|
20
|
Lichtenberger LM, Barron M and Marathi U:
Association of phosphatidylcholine and NSAIDs as a novel strategy
to reduce gastrointestinal toxicity. Drugs Today (Barc).
45:877–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lim YJ, Phan TM, Dial EJ, Graham DY and
Lichtenberger LM: In vitro and in vivo protection against
indomethacin-induced small intestinal injury by proton pump
inhibitors, acid pump antagonists, or
indomethacin-phosphatidylcholine. Digestion. 86:171–177. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Huang Y, Lichtenberger LM, Taylor M,
Bottsford-Miller JN, Haemmerle M, Wagner MJ, Lyons Y, Pradeep S, Hu
W, Previs RA, et al: Antitumor and antiangiogenic effects of
Aspirin-PC in ovarian cancer. Mol Cancer Ther. 15:2894–2904. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yao M, Lam EC, Kelly CR, Zhou W and Wolfe
MM: Cyclooxygenase-2 selective inhibition with NS-398 suppresses
proliferation and invasiveness and delays liver metastasis in
colorectal cancer. Br J Cancer. 90:712–719. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lichtenberger LM, Romero JJ and Dial EJ:
Surface phospholipids in gastric injury and protection when a
selective cyclooxygenase-2 inhibitor (Coxib) is used in combination
with aspirin. Br J Pharmacol. 150:913–919. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Burn J, Gerdes AM, Macrae F, Mecklin JP,
Moeslein G, Olschwang S, Eccles D, Evans DG, Maher ER, Bertario L,
et al: Long-term effect of aspirin on cancer risk in carriers of
hereditary colorectal cancer: An analysis from the CAPP2 randomised
controlled trial. Lancet. 378:2081–2087. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Movahedi M, Bishop DT, Macrae F, Mecklin
JP, Moeslein G, Olschwang S, Eccles D, Evans DG, Maher ER, Bertario
L, et al: Obesity, aspirin, and risk of colorectal cancer in
carriers of hereditary colorectal cancer: A prospective
investigation in the CAPP2 study. J Clin Oncol. 33:3591–3597. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Steinbach G, Lynch PM, Phillips RK,
Wallace MH, Hawk E, Gordon GB, Wakabayashi N, Saunders B, Shen Y,
Fujimura T, et al: The effect of celecoxib, a cyclooxygenase-2
inhibitor, in familial adenomatous polyposis. N Engl J Med.
342:1946–1952. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dial EJ, Doyen JR and Lichtenberger LM:
Phosphatidylcholine-associated nonsteroidal anti-inflammatory drugs
(NSAIDs) inhibit DNA synthesis and the growth of colon cancer cells
in vitro. Cancer Chemother Pharmacol. 57:295–300. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ranger GS: Current concepts in colorectal
cancer prevention with cyclooxygenase inhibitors. Anticancer Res.
34:6277–6282. 2014.PubMed/NCBI
|
|
30
|
Gurpinar E, Grizzle WE and Piazza GA:
NSAIDs inhibit tumorigenesis, but how? Clin Cancer Res.
20:1104–1113. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ma R, Yi B, Piazza GA and Xi Y:
Mechanistic role of MicroRNA in cancer chemoprevention by
nonsteroidal anti-inflammatory drugs. Curr Pharmacol Rep.
1:154–160. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tanaka Y, Tanaka T and Ishitsuka H:
Antitumor activity of indomethacin in mice bearing advanced colon
26 carcinoma compared with those with early transplants. Cancer
Res. 49:5935–5939. 1989.PubMed/NCBI
|
|
33
|
Darling RL, Romero JJ, Dial EJ, Akunda JK,
Langenbach R and Lichtenberger LM: The effects of aspirin on
gastric mucosal integrity, surface hydrophobicity, and
prostaglandin metabolism in cyclooxygenase knockout mice.
Gastroenterology. 127:94–104. 2004. View Article : Google Scholar : PubMed/NCBI
|
